Literature DB >> 33246516

Best Practices in the Management of Overweight and Obesity.

Beverly G Tchang1, Katherine H Saunders1, Leon I Igel2.   

Abstract

Obesity is a chronic disease caused by dysregulated energy homeostasis pathways that encourage the accumulation of adiposity, which in turn results in the development or exacerbation of weight-related comorbidities. Treatment of obesity relies on a foundation of lifestyle modification; weight loss pharmacotherapy, bariatric surgery and devices are additional tools to help patients achieve their health goals. Appropriate management of patients with obesity provides multiple metabolic benefits beyond weight loss.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiobesity medication; Bariatric surgery; Diet; Exercise; Nutrition; Obesity; Overweight; Weight

Mesh：

Substances：

Year:  2020        PMID： 33246516     DOI： 10.1016/j.mcna.2020.08.018

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  15 in total

1.  Surgery for Obesity and Weight-Related Diseases Changes the Inflammatory Profile in Women with Severe Obesity: a Randomized Controlled Clinical Trial.

Authors:  Alan Robson Trigueiro de Sousa; Wilson Rodrigues Freitas Junior; Eduardo Araujo Perez; Elias Jirjoss Ilias; Anderson Soares Silva; Vera Lucia Santos Alves; João Pedro Ribeiro Afonso; Miriã Cândida Oliveira; Adriano Luís Fonseca; Marcos Mota da Silva; Maria Eduarda Moreira Lino; Manoel Carneiro Oliveira Junior; Rodolfo Paula Vieira; Wilson José Sena Pedro; André Luis Lacerda Bachi; Giuseppe Insalaco; Carlos Alberto Malheiros; Luis Vicente Franco Oliveira
Journal:  Obes Surg       Date:  2021-09-23       Impact factor: 4.129

Review 2.  Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review.

Authors:  You Deng; Andrew Park; Lin Zhu; Wen Xie; Calvin Q Pan
Journal:  Ther Adv Chronic Dis       Date:  2022-07-04       Impact factor: 4.970

3.  Sinapic acid restores blood parameters, serum antioxidants, and liver and kidney functions in obesity.

Authors:  Khaled M M Koriem; Islam B Gad
Journal:  J Diabetes Metab Disord       Date:  2022-01-06

4.  Construction and Evaluation of a Nomogram to Predict Gallstone Disease Based on Body Composition.

Authors:  Jian-Hui Lu; Gen-Xi Tong; Xiang-Yun Hu; Rui-Fang Guo; Shi Wang
Journal:  Int J Gen Med       Date:  2022-07-02

Review 5.  Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases.

Authors:  Safaa H Hammoud; Ibrahim AlZaim; Yusra Al-Dhaheri; Ali H Eid; Ahmed F El-Yazbi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-02       Impact factor: 5.555

Review 6.  A Brief Overview of Oxidative Stress in Adipose Tissue with a Therapeutic Approach to Taking Antioxidant Supplements.

Authors:  Shima Taherkhani; Katsuhiko Suzuki; Ruheea Taskin Ruhee
Journal:  Antioxidants (Basel)       Date:  2021-04-13

7.  Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: A protocol for systematic review and meta-analysis.

Authors:  Yaxian Yang; Liting Wang; Jingfang Liu; Songbo Fu; Liyuan Zhou; Yan Wang
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

8.  Sedentary lifestyle and body composition in type 2 diabetes.

Authors:  Dan-Dan Li; Yang Yang; Zi-Yi Gao; Li-Hua Zhao; Xue Yang; Feng Xu; Chao Yu; Xiu-Lin Zhang; Xue-Qin Wang; Li-Hua Wang; Jian-Bin Su
Journal:  Diabetol Metab Syndr       Date:  2022-01-15       Impact factor: 3.320

9.  Nutrigenetic variants and response to diet/lifestyle intervention in obese subjects: a pilot study.

Authors:  Marica Franzago; Marta Di Nicola; Federica Fraticelli; Michele Marchioni; Liborio Stuppia; Ester Vitacolonna
Journal:  Acta Diabetol       Date:  2021-09-03       Impact factor: 4.280

Review 10.  A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders.

Authors:  Maddie Perdoncin; Alec Konrad; Joshua R Wyner; Samir Lohana; Sneha S Pillai; Duane G Pereira; Hari Vishal Lakhani; Komal Sodhi
Journal:  Front Mol Neurosci       Date:  2021-10-07       Impact factor: 6.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.